table of content
1 Home Insulin Delivery (Dosing) Devices Market Overview
1.1 Product Overview and Scope of Home Insulin Delivery (Dosing) Devices
1.2 Home Insulin Delivery (Dosing) Devices Segment by Type
1.2.1 Global Home Insulin Delivery (Dosing) Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Home Insulin Delivery (Dosing) Devices Segment by Application
1.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Home Insulin Delivery (Dosing) Devices Market Size Estimates and Forecasts
1.4.1 Global Home Insulin Delivery (Dosing) Devices Revenue 2017-2028
1.4.2 Global Home Insulin Delivery (Dosing) Devices Sales 2017-2028
1.4.3 Home Insulin Delivery (Dosing) Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Home Insulin Delivery (Dosing) Devices Market Competition by Manufacturers
2.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Home Insulin Delivery (Dosing) Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Home Insulin Delivery (Dosing) Devices Manufacturing Sites, Area Served, Product Type
2.5 Home Insulin Delivery (Dosing) Devices Market Competitive Situation and Trends
2.5.1 Home Insulin Delivery (Dosing) Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue
2.5.3 Global Home Insulin Delivery (Dosing) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario by Region
3.1 Global Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.3.1 North America Home Insulin Delivery (Dosing) Devices Sales by Country
3.3.2 North America Home Insulin Delivery (Dosing) Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.4.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country
3.4.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region
3.5.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.6.1 Latin America Home Insulin Delivery (Dosing) Devices Sales by Country
3.6.2 Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country
3.7.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Home Insulin Delivery (Dosing) Devices Historic Market Analysis by Type
4.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
4.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2022)
4.3 Global Home Insulin Delivery (Dosing) Devices Price by Type (2017-2022)
5 Global Home Insulin Delivery (Dosing) Devices Historic Market Analysis by Application
5.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)
5.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2022)
5.3 Global Home Insulin Delivery (Dosing) Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Tandem Diabetes Care
6.1.1 Tandem Diabetes Care Corporation Information
6.1.2 Tandem Diabetes Care Description and Business Overview
6.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
6.1.5 Tandem Diabetes Care Recent Developments/Updates
6.2 Biocon
6.2.1 Biocon Corporation Information
6.2.2 Biocon Description and Business Overview
6.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
6.2.5 Biocon Recent Developments/Updates
6.3 Roche Holding AG
6.3.1 Roche Holding AG Corporation Information
6.3.2 Roche Holding AG Description and Business Overview
6.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
6.3.5 Roche Holding AG Recent Developments/Updates
6.4 Insulet Corporation
6.4.1 Insulet Corporation Corporation Information
6.4.2 Insulet Corporation Description and Business Overview
6.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
6.4.5 Insulet Corporation Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
6.7.5 Eli Lilly and Company Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Corporation Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 Ypsomed Holding
6.11.1 Ypsomed Holding Corporation Information
6.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
6.11.5 Ypsomed Holding Recent Developments/Updates
6.12 Medtronic
6.12.1 Medtronic Corporation Information
6.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
6.12.5 Medtronic Recent Developments/Updates
6.13 Julphar
6.13.1 Julphar Corporation Information
6.13.2 Julphar Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
6.13.5 Julphar Recent Developments/Updates
6.14 Beta Bionics
6.14.1 Beta Bionics Corporation Information
6.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
6.14.5 Beta Bionics Recent Developments/Updates
6.15 Copernicus
6.15.1 Copernicus Corporation Information
6.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
6.15.5 Copernicus Recent Developments/Updates
6.16 Dance Biopharm
6.16.1 Dance Biopharm Corporation Information
6.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
6.16.5 Dance Biopharm Recent Developments/Updates
6.17 Debiotech
6.17.1 Debiotech Corporation Information
6.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
6.17.5 Debiotech Recent Developments/Updates
6.18 MannKind
6.18.1 MannKind Corporation Information
6.18.2 MannKind Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
6.18.5 MannKind Recent Developments/Updates
6.19 Owen Mumford
6.19.1 Owen Mumford Corporation Information
6.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
6.19.5 Owen Mumford Recent Developments/Updates
6.20 SOOIL
6.20.1 SOOIL Corporation Information
6.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.20.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
6.20.5 SOOIL Recent Developments/Updates
6.21 Valeritas
6.21.1 Valeritas Corporation Information
6.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
6.21.5 Valeritas Recent Developments/Updates
6.22 West Pharma
6.22.1 West Pharma Corporation Information
6.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.22.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
6.22.5 West Pharma Recent Developments/Updates
7 Home Insulin Delivery (Dosing) Devices Manufacturing Cost Analysis
7.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
7.4 Home Insulin Delivery (Dosing) Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Home Insulin Delivery (Dosing) Devices Distributors List
8.3 Home Insulin Delivery (Dosing) Devices Customers
9 Home Insulin Delivery (Dosing) Devices Market Dynamics
9.1 Home Insulin Delivery (Dosing) Devices Industry Trends
9.2 Home Insulin Delivery (Dosing) Devices Market Drivers
9.3 Home Insulin Delivery (Dosing) Devices Market Challenges
9.4 Home Insulin Delivery (Dosing) Devices Market Restraints
10 Global Market Forecast
10.1 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Type (2023-2028)
10.2 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Application (2023-2028)
10.3 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
